Looks like last round of sellers have moved on and the register has tightened. I assume the recent buyers now want to see some price action which means there will be less sellers holding large profits who want to trade for certain the short term. I suspect the register is filling up with longer term holders who are confident in the future of LTP.
Next move might be announcing another product as well as giving clarity on what the timetable for commercialisation looks like.
Shareholders should realise the sale of product to date is to put the product in more hands for testing NOT to achieve revenue. That stage will come. The sales to date provide data and rom all accounts that data has been outstanding eg. Little side effects if any compared to Viagra and faster acting.
I understand repeat usage has been strong and the result is always consistent for the consumer.
Next stop $3+ post AGM.
LTP Price at posting:
$1.31 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)